PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente (Andrea Park/FierceBiotech)

Andrea Park / FierceBiotech:
PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente  —  If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI’s (ahem) path forward appears to be paved in gold.

Source: http://www.techmeme.com/210521/p24#a210521p24

attachement

More To Explore

Do You Want To learn about our IT managed Services?

Contact Us

GENERAL SALES HOURS: MON-FRI 09:00 - 19:00, SAT-SUN 10:00 - 16:00

2717 Commercial Center Blvd.,
Suite E200, Katy, TX, 77494

Purple Falcon Partners

Industries We Serve

Weekly Newsletter